These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6390258)

  • 61. REVIEW OF SOME OF THE MORE RECENT ADVANCES IN THE STUDY OF BLOOD DISEASES.
    Sturgis CC
    Science; 1935 Apr; 81(2103):367-71. PubMed ID: 17769423
    [No Abstract]   [Full Text] [Related]  

  • 62. PREVENTION OF BLOOD COAGULATION BY CYSTEINE.
    Mueller JH; Sturgis S
    Science; 1932 Jan; 75(1935):140. PubMed ID: 17790719
    [No Abstract]   [Full Text] [Related]  

  • 63. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 65. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Blood coagulation changes and pathogenesis of diabetic retinopathy. Recent advances].
    Porta M; Nuzzi R; Passera P
    Minerva Med; 1984 Oct; 75(41):2407-20. PubMed ID: 6390258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inflammation, endothelium, and coagulation in sepsis.
    Schouten M; Wiersinga WJ; Levi M; van der Poll T
    J Leukoc Biol; 2008 Mar; 83(3):536-45. PubMed ID: 18032692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
    Blann AD; Lip GY
    Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Progress of research on pathogenesis and medical treatment of diabetic retinopathy].
    Geng S; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):76-81. PubMed ID: 18510248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Recent advances in the studies of genetic polymorphisms in diabetic retinopathy].
    Wang N; Xu X
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):563-6. PubMed ID: 16857146
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.